Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Begin-Period-Cashflow" stands at 11.80 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 29.72 percent compared to the value the year prior.
The 1 year change in percent is 29.72.
The 3 year change in percent is -50.22.
The 5 year change in percent is -39.05.
The 10 year change in percent is 19.96.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Begin Period Cashflow | 905,699,262,464.00 |
![]() | Johnson & Johnson - Begin Period Cashflow | 486,508,953,600.00 |
![]() | AbbVie Inc - Begin Period Cashflow | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Begin Period Cashflow | 280,205,508,085.11 |
![]() | Novartis AG - Begin Period Cashflow | 255,096,620,580.91 |